Coon; Timothy Richard

Patent Applications and Registrations

Patent applications and USPTO patent grants for Coon; Timothy Richard.The latest application filed is for "modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators".

Company Profile

14.16.23

Coon; Timothy Richard - Carlsbad CA
Coon; Timothy Richard - Boston MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Modulators of cystic fibrosis transmembrane conductance regulator Grant 11,426,407 - Miller , et al. August 30, 2	2022-08-30
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the Modulators App 20220106331 - Clemens; Jeremy J. ; et al.	2022-04-07
Methods Of Treatment For Cystic Fibrosis App 20220047564 - ALTSHULER; David M. ; et al.	2022-02-17
Gonadotropin-releasing Hormone Receptor Antagonists And Methods Relating Thereto App 20210284653 - BEATON; Graham ; et al.	2021-09-16
Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators Grant 11,066,417 - Clemens , et al. July 20, 2	2021-07-20
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto Grant 10,941,159 - Beaton , et al. March 9, 2	2021-03-09
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20210052584 - Miller; Mark Thomas ; et al.	2021-02-25
Process Of Making Cftr Modulators App 20210047345 - Angell; Paul ; et al.	2021-02-18
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20210047350 - Anderson; Corey Don ; et al.	2021-02-18
Crystalline Forms Of Cftr Modulators App 20210047323 - Shi; Yi ; et al.	2021-02-18
Modulators of cystic fibrosis transmembrane conductance regulator Grant 10,758,534 - Miller , et al. Sep	2020-09-01
Modulators of cystic fibrosis transmembrane conductance regulator Grant 10,738,030 - Bear , et al. A	2020-08-11
Gonadotropin-releasing Hormone Receptor Antagonists And Methods Relating Thereto App 20200095259 - BEATON; Graham ; et al.	2020-03-26
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20190269683 - Miller; Mark Thomas ; et al.	2019-09-05
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Proces App 20190248809 - Clemens; Jeremy J. ; et al.	2019-08-15
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto Grant 10,336,769 - Beaton , et al.	2019-07-02
Modulators of cystic fibrosis transmembrane conductance regulator Grant 10,258,624 - Miller , et al.	2019-04-16
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20190055220 - Bear; Brian ; et al.	2019-02-21
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20180185364 - Miller; Mark Thomas ; et al.	2018-07-05
Gonadotropin-releasing Hormone Receptor Antagonists And Methods Relating Thereto App 20170320888 - Beaton; Graham ; et al.	2017-11-09
Modulators of cystic fibrosis transmembrane conductance regulator Grant 9,782,408 - Miller , et al. October 10, 2	2017-10-10
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20170196862 - Miller; Mark Thomas ; et al.	2017-07-13
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto Grant 9,422,310 - Beaton , et al. August 23, 2	2016-08-23
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator App 20160095858 - Miller; Mark Thomas ; et al.	2016-04-07
Gonadotropin-releasing Hormone Receptor Antagonists And Methods Relating Thereto App 20150183800 - Beaton; Graham ; et al.	2015-07-02
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto Grant 8,952,161 - Beaton , et al. February 10, 2	2015-02-10
Gonadotropin-releasing Hormone Receptor Antagonists And Methods Relating Thereto App 20140024665 - Beaton; Graham ; et al.	2014-01-23
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto Grant 8,507,536 - Beaton , et al. August 13, 2	2013-08-13
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto Grant 8,481,738 - Beaton , et al. July 9, 2	2013-07-09
Gonadotropin-releasing Hormone Receptor Antagonists And Methods Relating Thereto App 20130040975 - Beaton; Graham ; et al.	2013-02-14
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto Grant 8,263,588 - Beaton , et al. September 11, 2	2012-09-11
Gonadotropin-releasing Hormone Receptor Antagonists And Methods Relating Thereto App 20120122891 - Beaton; Graham ; et al.	2012-05-17
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto Grant 8,084,614 - Beaton , et al. December 27, 2	2011-12-27
Gonadotropin-releasing Hormone Receptor Antagonists And Methods Relating Thereto App 20100184741 - Ashweek; Neil ; et al.	2010-07-22
Gonadotropin-releasing Hormone Receptor Antagonists And Methods Relating Thereto App 20100152207 - Beaton; Graham ; et al.	2010-06-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.